| Secondary |
| Schizophrenia |
32.2% |
| Product Used For Unknown Indication |
19.7% |
| Insomnia |
9.8% |
| Drug Use For Unknown Indication |
9.1% |
| Depression |
5.2% |
| Schizophrenia, Disorganised Type |
3.9% |
| Delirium |
3.4% |
| Aggression |
2.7% |
| Impulsive Behaviour |
2.7% |
| Drug Exposure During Pregnancy |
1.8% |
| Drug Exposure Via Breast Milk |
1.8% |
| Prophylaxis |
1.8% |
| Schizophrenia, Paranoid Type |
1.4% |
| Extrapyramidal Disorder |
0.9% |
| Constipation |
0.7% |
| Hyperlipidaemia |
0.7% |
| Parkinsonism |
0.7% |
| Sleep Disorder |
0.7% |
| Acarodermatitis |
0.5% |
| Bipolar Disorder |
0.5% |
|
| Drug Toxicity |
9.7% |
| Neuroleptic Malignant Syndrome |
8.1% |
| Weight Decreased |
8.1% |
| White Blood Cell Count Increased |
8.1% |
| Pulmonary Embolism |
6.5% |
| Suicide Attempt |
6.5% |
| Akathisia |
4.8% |
| Cardiac Failure |
4.8% |
| Myocardial Infarction |
4.8% |
| Rhabdomyolysis |
4.8% |
| Sudden Death |
4.8% |
| Anaemia |
3.2% |
| Apgar Score Low |
3.2% |
| Blood Creatine Phosphokinase Increased |
3.2% |
| Cardiac Failure Acute |
3.2% |
| Cardio-respiratory Arrest |
3.2% |
| Drug Withdrawal Syndrome Neonatal |
3.2% |
| Multiple Drug Overdose |
3.2% |
| Respiratory Failure |
3.2% |
| Rib Fracture |
3.2% |
|
| Concomitant |
| Schizophrenia |
36.8% |
| Drug Use For Unknown Indication |
15.4% |
| Constipation |
6.1% |
| Schizophrenia, Paranoid Type |
5.9% |
| Insomnia |
4.8% |
| Psychotic Disorder |
3.9% |
| Depression |
3.1% |
| Parkinsonism |
2.7% |
| Schizophrenia, Disorganised Type |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Cerebral Palsy |
2.0% |
| Mental Retardation Severity Unspecified |
2.0% |
| Autism |
1.8% |
| Asthma |
1.7% |
| Hiv Infection |
1.7% |
| Prophylaxis |
1.6% |
| Dementia Alzheimer's Type |
1.4% |
| Ileus |
1.3% |
| Delirium |
1.2% |
| Diabetes Mellitus |
1.2% |
|
| Pneumonia Aspiration |
13.3% |
| Water Intoxication |
12.6% |
| Rhabdomyolysis |
7.4% |
| Hepatic Function Abnormal |
5.9% |
| Loss Of Consciousness |
5.9% |
| Affect Lability |
5.2% |
| Neuroleptic Malignant Syndrome |
5.2% |
| Pneumonia |
5.2% |
| Psychotic Disorder |
5.2% |
| Vomiting |
4.4% |
| Agitation |
3.7% |
| Malaise |
3.7% |
| Sudden Death |
3.7% |
| Mania |
3.0% |
| Soliloquy |
3.0% |
| Tachycardia |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Completed Suicide |
2.2% |
| Epilepsy |
2.2% |
| Grand Mal Convulsion |
2.2% |
|
| Interacting |
| Schizophrenia |
57.1% |
| Intentional Overdose |
42.9% |
|
| Long Qt Syndrome |
50.0% |
| Neuroleptic Malignant Syndrome |
50.0% |
|
